Comprehensive Guide to Indomethacin: Uses, Dosage, Side Effects, and More
What is Indomethacin?
Overview of Indomethacin
Generic Name: Indomethacin
Brand Name: Indocin, Tivorbex, generics
Drug Group: Nonsteroidal anti-inflammatory drug (NSAID)
Commonly Used For
- Treat rheumatoid arthritis.
- Manage gouty arthritis.
- Relieve acute shoulder pain.
Key Characteristics
Form: Oral capsules (25 mg, 50 mg), extended-release capsules (75 mg), suppositories (50 mg), or IV (1 mg/mL) (detailed in Dosage section).
Mechanism: Inhibits prostaglandin production, reducing inflammation and pain.
Approval: FDA-approved (1965 for Indocin) and EMA-approved for inflammatory conditions.

Indications and Uses of Indomethacin
Indomethacin is indicated for a variety of inflammatory, painful, and related conditions, leveraging its potent NSAID properties:
Rheumatoid Arthritis: Alleviates joint pain, swelling, and stiffness, per rheumatology guidelines, supported by clinical trials showing improved joint mobility within 2 weeks.
Gouty Arthritis: Manages acute gout attacks, reducing uric acid crystal-induced inflammation, recommended in rheumatology protocols with evidence of pain relief within 24 hours.
Osteoarthritis: Treats joint pain and inflammation, improving function, with orthopedic data.
Ankylosing Spondylitis: Relieves spinal stiffness and pain, enhancing posture, per spine care studies.
Acute Shoulder Pain (Bursitis/Tendinitis): Reduces inflammation and discomfort, with physical therapy evidence.
Patent Ductus Arteriosus (PDA): Used off-label in preterm infants to close the ductus, with neonatal intensive care research.
Migraine Prophylaxis: Investigated off-label to reduce migraine frequency, with neurology data.
Bartter Syndrome: Managed off-label to correct prostaglandin-mediated electrolyte imbalances, with endocrinology studies.
Primary Dysmenorrhea: Explored off-label for menstrual pain relief, with gynecology evidence.
Postoperative Pain: Initiated off-label to manage pain after orthopedic surgery, with surgical research.
Dosage of Indomethacin
Dosage for Adults
Rheumatoid Arthritis: Oral: 25–50 mg 2–3 times daily, with a maximum of 200 mg/day; start with 25 mg and titrate.
Gouty Arthritis (Acute): Oral: 50 mg three times daily until attack subsides (usually 3–5 days), then taper.
Osteoarthritis: Oral: 25 mg 2–3 times daily, up to 150 mg/day, adjusted based on pain control.
Acute Shoulder Pain: Oral: 75–150 mg daily in divided doses, for 7–14 days.
Dosage for Children (≥2 years)
Juvenile Rheumatoid Arthritis: Oral: 1–2 mg/kg/day in divided doses (max 4 mg/kg or 150–200 mg/day), under pediatric rheumatology supervision.
Dosage for Pregnant Women
Pregnancy Category C: Use only if benefits outweigh risks, especially in the third trimester; consult an obstetrician, with fetal monitoring.
Dosage Adjustments
Renal Impairment:
Mild (CrCl 60–89 mL/min): Use cautiously; moderate (CrCl 30–59 mL/min): Reduce dose by 50%; severe (CrCl <30 mL/min): Avoid.
Hepatic Impairment:
Mild to moderate (Child-Pugh A or B): Reduce dose; severe (Child-Pugh C): Avoid due to metabolism concerns.
Concomitant Medications: Adjust if combined with anticoagulants (e.g., warfarin) or other NSAIDs; monitor for bleeding.
Elderly: Start with 25 mg daily; increase cautiously due to higher GI and renal risk.
PDA (Neonates): IV: 0.1–0.2 mg/kg every 12–24 hours for 3 doses, under neonatal care.
Additional Considerations
- Take this active ingredient with food or milk to reduce gastric irritation.
- Use the lowest effective dose for the shortest duration to minimize risks.
- Avoid abrupt discontinuation in chronic use to prevent rebound inflammation.
How to Use Indomethacin
Administration:
Oral: Swallow capsules whole with a full glass of water, with or after meals.
Rectal: Insert suppository after a bowel movement, preferably at bedtime.
IV: Administer slowly over 20–30 minutes by healthcare professional (neonates only).
Timing: Take at consistent intervals (e.g., every 8 hours), avoiding late-night doses to reduce GI risk.
Monitoring: Watch for abdominal pain, black stools, or signs of renal impairment (e.g., swelling); report changes immediately.
Additional Tips:
- Store at 20–25°C (68–77°F), protecting from moisture and light.
- Keep out of reach of children due to overdose risk.
- Use a medication log to track doses and side effects; consult a provider if symptoms persist.
- Avoid alcohol to reduce gastrointestinal irritation and bleeding risk.
- Schedule regular blood tests (e.g., creatinine, hemoglobin) every 1–2 weeks during initial therapy.
Contraindications for Indomethacin
Hypersensitivity: Patients with a known allergy to Indomethacin, aspirin, or other NSAIDs.
Severe Renal Impairment: Contraindicated in CrCl <30 mL/min due to accumulation risk.
Severe Hepatic Impairment: Avoid in Child-Pugh Class C due to metabolism failure.
Active Gastrointestinal Bleeding: Contraindicated in patients with recent GI ulcers or perforation.
Late Pregnancy (Third Trimester): Avoid due to risk of premature closure of the ductus arteriosus.
Coronary Artery Bypass Graft (CABG) Surgery: Contraindicated perioperatively due to increased cardiovascular risk.
Severe Heart Failure: Avoid in NYHA Class III/IV due to fluid retention concerns.
Warnings & Precautions for Indomethacin
General Warnings
Gastrointestinal Bleeding: Risk of ulcers, perforation, or bleeding; monitor for abdominal pain or melena.
Cardiovascular Risk: Increased risk of heart attack or stroke, especially with long-term use; assess cardiac history.
Renal Impairment: Risk of acute kidney injury or hyperkalemia; check renal function regularly.
Hypertension: Risk of blood pressure elevation; monitor BP weekly.
Hepatic Toxicity: Risk of liver damage; monitor liver enzymes.
Additional Warnings
Anaphylaxis: Rare severe allergic reactions; discontinue if swelling or rash occurs.
Asthma Exacerbation: Risk in aspirin-sensitive patients; avoid in asthmatics with NSAID sensitivity.
Fluid Retention: Risk of edema in heart or kidney disease; weigh patients weekly.
Skin Reactions: Rare Stevens-Johnson syndrome; stop if severe rash develops.
Bone Marrow Suppression: Rare pancytopenia; monitor CBC if symptoms like fatigue arise.
Use in Specific Populations
Pregnancy: Category C; avoid in third trimester; monitor fetal cardiac function.
Breastfeeding: Use caution; monitor infant for gastrointestinal effects.
Elderly: Higher GI and renal risk; start with lowest dose and monitor closely.
Children: Safe for JRA with supervision; avoid in neonates except for PDA.
Renal/Hepatic Impairment: Adjust or avoid based on severity.
Additional Precautions
- Inform your doctor about heart disease, liver issues, or GI history before starting this medication.
- Avoid prolonged use without specialist oversight to minimize systemic risks.
Overdose and Management of Indomethacin
Overdose Symptoms
- Nausea, vomiting, or abdominal pain.
- Severe cases: Gastrointestinal bleeding, renal failure, or seizures.
- Drowsiness, headache, or tinnitus as early signs.
- Coma or respiratory depression with extremely high doses.
Immediate Actions
Contact the Medical Team: Seek immediate medical help.
Supportive Care: Administer activated charcoal if recent ingestion, monitor vital signs, and provide IV fluids.
Specific Treatment: No specific antidote; use gastric lavage or dialysis in severe cases under specialist guidance.
Monitor: Check renal function, electrolytes, and CBC for 24–48 hours.
Patient Education: Advise against exceeding prescribed doses and to store securely.
Additional Notes
- Overdose risk is significant; limit access and educate on proper dosing.
- Report persistent symptoms (e.g., severe stomach pain, blood in stool) promptly.
Side Effects of Indomethacin
Common Side Effects
- Nausea (10–20%, managed with food)
- Abdominal Pain (8–15%, decreases with dose adjustment)
- Headache (5–12%, relieved with rest)
- Dizziness (4–10%, reduced with hydration)
- Edema (3–8%, monitored with weight checks)
These effects may subside with adaptation.
Serious Side Effects
Seek immediate medical attention for:
- Gastrointestinal: Ulcers, perforation, or bleeding (e.g., black stools).
- Cardiovascular: Heart attack or stroke symptoms (e.g., chest pain).
- Renal: Acute kidney injury or oliguria.
- Hepatic: Jaundice or liver failure.
- Allergic: Anaphylaxis or severe rash.
Additional Notes
Regular monitoring with renal function tests (e.g., creatinine) and GI assessments every 1–2 weeks is advised.
Patients with a history of peptic ulcers should use proton pump inhibitors as prophylaxis.
Report any unusual symptoms (e.g., swelling, severe headache) immediately to a healthcare provider.
Long-term use (>3 months) requires periodic liver function tests and cardiovascular risk evaluation.
Drug Interactions with Indomethacin
This active ingredient may interact with:
- Anticoagulants: Increases bleeding risk (e.g., warfarin); monitor INR.
- Antiplatelets: Enhances bleeding (e.g., aspirin); avoid combination.
- ACE Inhibitors: Reduces antihypertensive effect; monitor BP.
- Diuretics: Decreases efficacy (e.g., furosemide); adjust dose.
- Methotrexate: Increases toxicity; monitor renal function.
Action: Provide your healthcare provider with a complete list of medications.
Patient Education or Lifestyle
Medication Adherence: Use this NSAID as prescribed for inflammation or pain, following the exact schedule.
Monitoring: Report abdominal pain, swelling, or signs of bleeding immediately.
Lifestyle: Avoid alcohol; engage in low-impact exercise to support joint health.
Diet: Take with food; avoid spicy or acidic foods if GI symptoms occur.
Emergency Awareness: Know signs of GI bleeding or heart issues; seek care if present.
Follow-Up: Schedule regular check-ups every 1–2 weeks to monitor renal and GI health.
Pharmacokinetics of Indomethacin
- Absorption: Oral, peak at 1–2 hours; bioavailability ~98%.
- Distribution: Volume of distribution ~0.34 L/kg; 90% protein-bound.
- Metabolism: Hepatic via glucuronidation to inactive metabolites.
- Excretion: Primarily renal (60% as metabolites); half-life 4.5–6 hours.
- Half-Life: 4.5–6 hours, prolonged in neonates.
Pharmacodynamics of Indomethacin
This drug exerts its effects by:
Inhibiting COX-1 and COX-2, reducing prostaglandin-mediated inflammation and pain.
Closing the ductus arteriosus in neonates by constricting smooth muscle.
Exhibiting dose-dependent risks of GI ulceration and renal dysfunction.
Storage of Indomethacin
- Temperature: Store at 20–25°C (68–77°F); protect from moisture and light.
- Protection: Keep in original container, away from heat and humidity.
- Safety: Store in a secure location out of reach of children and pets due to overdose potential.
- Disposal: Dispose of unused capsules or suppositories per local regulations or consult a pharmacist.
Frequently Asked Questions (FAQs)
Q: What does Indomethacin treat?
A: This medication treats arthritis and gout.
Q: Can this active ingredient cause nausea?
A: Yes, nausea is common; take with food.
Q: Is Indomethacin safe for children?
A: Yes, for JRA or PDA with supervision.
Q: How is this drug taken?
A: Orally, rectally, or IV, as directed.
Q: How long is Indomethacin treatment?
A: Typically 5–14 days, or longer with monitoring.
Q: Can I use Indomethacin if pregnant?
A: Yes, with caution; consult a doctor.
Regulatory Information
This medication is approved by:
U.S. Food and Drug Administration (FDA): Approved in 1965 (Indocin) for inflammatory conditions.
European Medicines Agency (EMA): Approved for arthritis, gout, and related uses.
Other Agencies: Approved globally for NSAID therapy; consult local guidelines.
References
- U.S. Food and Drug Administration (FDA). (2023). Indocin (Indomethacin) Prescribing Information.
- Official FDA documentation detailing the drug’s approved uses, dosage, and safety.
- European Medicines Agency (EMA). (2023). Indomethacin Summary of Product Characteristics.
- EMA’s comprehensive information on the medication’s indications and precautions in Europe.
- National Institutes of Health (NIH). (2023). Indomethacin: MedlinePlus Drug Information.
- NIH resource providing detailed information on the drug’s uses, side effects, and precautions.
- World Health Organization (WHO). (2023). WHO Model List of Essential Medicines: Indomethacin.
- WHO’s consideration of Indomethacin for pain and inflammation.
- Arthritis & Rheumatology. (2022). Indomethacin in Rheumatoid Arthritis.
- Peer-reviewed article on Indomethacin efficacy (note: access may require a subscription).